Alzheimer's Tied to Mutation Harming Immune Response
Alzheimer’s researchers and drug companies have for years concentrated on one hallmark of Alzheimer’s disease: the production of toxic shards of a protein that accumulate in plaques on the brain.View The New York Times Article (11/14/2012)

API Echoes DIAN: Biomarker Changes Precede Symptoms by 20 Years
Evidence keeps building that the first signs of Alzheimer’s disease appear decades before symptoms. View the Alzheimer Research Forum Article (11/8/2012)

Three Drugs to Be Tested to Stave Off Alzheimer's
Scientists have selected three different types of Alzheimer’s drugs to be tested in the first large-scale international attempt to prevent the disease in people who are otherwise doomed to get it. View The New York Times Article (10/10/2012)

New Alzheimer's marker strongly predicts mental declineA new marker of Alzheimer's disease can predict how rapidly a patient's memory and other mental abilities will decline after the disorder is diagnosed, researchers at Washington University School of Medicine in St. Louis have found.View Article via EurekAlert (3/5/12)

Washington People: Randall Bateman
Innovations advance Alzheimer's research --
As a faculty member at the School of Medicine since 2006, Bateman focuses his research on Alzheimer’s disease. He led the development of a technique known as stable isotope-linked kinetics (SILK) that made it possible to resolve a critical question about the disease.View Article via Washington University Newsroom (2/17/2012)

Late- and Early-Onset AD--Not So Distant at Genetic Level
The distinction between early-onset AD and late-onset disease is “probably artificial,” said Alison Goate of Washington University in St. Louis, Missouri, senior author on the paper.View Article via Alzheimer Research Forum (2/14/2012)

Could Sleep Problems Predict Alzheimer's?
The poorer your sleep, the more likely you may be to develop Alzheimer's disease, according to a new study.View Article via WebMD (2/14/2012)